TOP TIERMARKET NEWSWIRE
Movers explained · July 30, 2026

Why Is BOSTON SCIENTIFIC CO (BSX) Stock Moving Today?

By the Top Tier Newswire AI Desk · July 16, 2026 at 10:38 AM ET · reviewed against 20 wire stories

BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 20 stories on BSX across 13 sources in the last 36 hours, with AI sentiment reading mixed (avg 49/100).

Boston Scientific Co (BSX) is moving lower today after hitting a 52-week low. The stock opened with a small gap higher but quickly reversed course amid broader market concerns and profit-taking. The decline follows a string of analyst price target reductions and a deteriorating sentiment trend.

What Happened

Boston Scientific fell to a 52-week low on Wednesday as Wall Street concerns and profit-taking sent the stock lower. The stock opened at $43.35, a 0.7% gap up from the previous close, but failed to hold that level. By the end of the session, the stock had settled near $44.57, with a high of $45.45 and a low of $43.04. The stock traded on 4.0 million shares, which is just 0.2 times the 3-month daily average. The recent price action has seen the stock fall 2.4% over the last 8 sessions, from $45.66 to $44.57.

Analysts have maintained positive ratings on the stock but have lowered their price targets. Mizuho, RBC Capital, Needham, and Evercore ISI Group all maintain Outperform or Buy ratings but have reduced their price targets to between $57 and $85. Boston Scientific reported a trailing twelve-month revenue increase of 17.4% and a net margin of 17.3%, but its beta of 0.58 indicates it has been less volatile than the broader market.

What The Data Shows

The stock’s 52-week range is $42.25 to $109.50, and it is currently trading near the lower end of that range. Unusual options activity has been observed, with $360K in call premium and $269K in put premium traded, the largest single print being $360K. On July 16, the stock printed one fresh 52-week low. Recent insider transactions show three directors buying shares totaling $554K in the last 90 days. Meanwhile, recent congressional trades include both buys and sells, with Rep. Ro Khanna disclosing a recent purchase of $1,001-$15,000.

What To Watch

Boston Scientific does not have an upcoming earnings date listed. Investors should monitor the breadth of analyst coverage and any further price target adjustments.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.

BSX by the numbers

7 sessions: +3.94%Coverage: 20 stories / 13 sourcesAI sentiment: 49/100 (mixed)Mkt cap: $66.3BP/E: 19.052w: $42.25 to $109.50
BSX · Jul 29 session (5-min) · +0.96% vs prior close · updated 1:26 PM ET
$41.60$44.91$48.21prev close $46.06$46.507:00 AM8:36 AM10:12 AM11:48 AM1:25 PM7:00 AM · $47.867:05 AM · $47.827:10 AM · $47.507:15 AM · $47.807:20 AM · $47.607:25 AM · $47.627:30 AM · $47.627:35 AM · $47.207:40 AM · $46.997:45 AM · $46.707:50 AM · $46.007:55 AM · $45.838:00 AM · $45.258:05 AM · $43.758:10 AM · $43.008:15 AM · $41.958:20 AM · $42.508:25 AM · $42.608:30 AM · $42.908:35 AM · $43.988:40 AM · $43.508:45 AM · $43.518:50 AM · $43.148:55 AM · $43.129:00 AM · $42.909:05 AM · $43.009:10 AM · $43.019:15 AM · $42.909:20 AM · $42.779:25 AM · $42.519:30 AM · $43.089:35 AM · $43.339:40 AM · $43.049:45 AM · $44.599:50 AM · $45.019:55 AM · $45.2410:00 AM · $45.4810:05 AM · $45.6710:10 AM · $45.6010:15 AM · $45.2010:20 AM · $45.3710:25 AM · $45.4110:30 AM · $45.3510:35 AM · $45.6110:40 AM · $46.2610:45 AM · $45.9710:50 AM · $45.8710:55 AM · $46.1911:00 AM · $46.1711:05 AM · $46.3611:10 AM · $46.3811:15 AM · $46.4711:20 AM · $46.4011:25 AM · $46.6711:30 AM · $46.7211:35 AM · $46.6511:40 AM · $46.4811:45 AM · $46.3811:50 AM · $46.3311:55 AM · $46.5712:00 PM · $46.6912:05 PM · $46.5812:10 PM · $46.7112:15 PM · $46.5912:20 PM · $46.5312:25 PM · $46.2112:30 PM · $46.2712:35 PM · $46.2812:40 PM · $46.2912:45 PM · $46.0412:50 PM · $46.2212:55 PM · $46.111:00 PM · $46.331:05 PM · $46.231:10 PM · $46.301:15 PM · $46.351:20 PM · $46.451:25 PM · $46.50
AI sentiment, last 36h · averaged over 20 stories · 49/100 neutral
AI sentiment 49/100 (neutral)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 10 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowSeeking Alpha · sentiment 50 · Boston Scientific Corporation 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha · 50Boston Scientific Corporation 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha · sentiment 38 · Boston Scientific slips as outlook trails consensusSeeking Alpha · 38Boston Scientific slips as outlook trails consensusQuartz · sentiment 38 · Boston Scientific Q2 2026 earnings: profit forecast cut on Watchman slowdown - qz.comQuartz · 38Boston Scientific Q2 2026 earnings: profit forecast cut on Watchman slowdown - qz.comQuartz · sentiment 42 · Boston Scientific beat earnings expectations but slashed its annual profit forecastQuartz · 42Boston Scientific beat earnings expectations but slashed its annual profit forecastQuartz · sentiment 63 · Boston Scientific Bets on Growth Through Strategic M&A Deals - qz.comQuartz · 63Boston Scientific Bets on Growth Through Strategic M&A Deals - qz.comYahoo Top · sentiment 48 · Boston Scientific reports positive Q2 results yet opts to trim 2026 outlookYahoo Top · 48Boston Scientific reports positive Q2 results yet opts to trim 2026 outlookSeeking Alpha · sentiment 50 · Boston Scientific Corporation (BSX) Q2 2026 Earnings Call TranscriptSeeking Alpha · 50Boston Scientific Corporation (BSX) Q2 2026 Earnings Call TranscriptSeeking Alpha · sentiment 42 · Boston Scientific expects 2026 organic revenue growth of 5%-6% and outlines $500M run-rate savings exiting 2029Seeking Alpha · 42Boston Scientific expects 2026 organic revenue growth of 5%-6% and outlines $500M run-rat…Yahoo Top · sentiment 68 · Boston Scientific beats second quarter expectations, raises full-year outlookYahoo Top · 68Boston Scientific beats second quarter expectations, raises full-year outlookInvesting.com Analyst Ratings · sentiment 38 · BTIG cuts Boston Scientific stock price target on weaker outlookInvesting.com Analyst Ratings · 38BTIG cuts Boston Scientific stock price target on weaker outlook
14h agoInvesting.com Analyst RatingsBEARISH 38Analyst

BTIG cuts Boston Scientific stock price target on weaker outlook

BTIG cuts Boston Scientific stock price target on weaker outlook

17h agoYahoo TopBULLISH 68Earnings

Boston Scientific beats second quarter expectations, raises full-year outlook

Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while raising its full-year sales outlook. The medical device company posted adjusted earnings per share of $0.86, ahead of the $0.83 consensus...

17h agoSeeking AlphaBEARISH 42Earnings

Boston Scientific expects 2026 organic revenue growth of 5%-6% and outlines $500M run-rate savings exiting 2029

Boston Scientific (BSX) Q2 2026 earnings call: Q2 results, lowered 2026 guidance, WATCHMAN/EP pressures, and $500M restructuring plan.

17h agoSeeking AlphaNEUTRAL 50Earnings

Boston Scientific Corporation (BSX) Q2 2026 Earnings Call Transcript

Boston Scientific Corporation (BSX) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDTCompany ParticipantsLauren Tengler - Director of Investor...

17h agoYahoo TopNEUTRAL 48Earnings

Boston Scientific reports positive Q2 results yet opts to trim 2026 outlook

Boston's tempered 2026 outlook is likely due in part to its recently announced plans to initiate a global restructuring programme.

17h agoQuartzBULLISH 63M&A

Boston Scientific Bets on Growth Through Strategic M&A Deals - qz.com

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

20h agoQuartzBEARISH 42Earnings

Boston Scientific beat earnings expectations but slashed its annual profit forecast

The medical device maker topped second-quarter expectations but now sees full-year adjusted EPS of $3.28 to $3.32, down from a prior range of $3.34 to $3.41

20h agoQuartzBEARISH 38Earnings

Boston Scientific Q2 2026 earnings: profit forecast cut on Watchman slowdown - qz.com

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

20h agoSeeking AlphaBEARISH 38Earnings

Boston Scientific slips as outlook trails consensus

Boston Scientific (BSX) stock falls after the company

20h agoSeeking AlphaNEUTRAL 50Earnings

Boston Scientific Corporation 2026 Q2 - Results - Earnings Call Presentation

2026-07-29. The following slide deck was published by Boston Scientific Corporation in conjunction with their 2026 Q2 earnings call.

Frequently asked questions

Why is BSX stock moving today?

BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 20 stories on BSX across 13 sources in the last 36 hours, with AI sentiment reading mixed (avg 49/100). The most recent driver: "BTIG cuts Boston Scientific stock price target on weaker outlook" (Investing.com Analyst Ratings).

Is BSX a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of BSX coverage reads 49/100 over 20 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on BSX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier BSX move explainers: 2026-07-16